Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Upper-Extremity Plyometric Combined Strength Training in Overhead Athletes With Shoulder Instability Trial completed National Yang Ming Chiao Tung UniversityNot applicable NCT05857540
  2. Minor: Mobilization and Feeding After Lobectomy Trial completed Ege UniversityNot applicable NCT07749950
  3. Minor: Digitally Enabled District (DED 2.0) Ecosystem on the Completeness and Timeliness of Maternal and Neonatal Services in Primary Health Care Enrollment closed, study ongoing Summit Institute for Development, IndonesiaNot applicable NCT07842224
  4. Minor: Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section Primary completion pushed from Nov 1, 2026 to Dec 1, 2026 Tanta UniversityPhase 3 NCT07661758
  5. Minor: Piloting Novel Interventional Strategies to Improve Nicotine Pouches as a Substitute for Smoking Primary completion pushed from Oct 2026 to Feb 28, 2027 Medical University of South CarolinaPhase 4 NCT07625956
  6. Minor: Low and High Nicotine Tobacco Free Nicotine Pouches Primary completion pushed from Nov 1, 2026 to Jan 1, 2027 Medical University of South CarolinaNot applicable NCT06678789
  7. Minor: STROKE 120 ACTION Trial Primary completion pushed from Nov 30, 2026 to Jan 24, 2027 Shanghai Minhang Central HospitalNot applicable NCT07135310
  8. Minor: Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers Primary and study completion pushed from Jul 2027 to Nov 2027 University of Colorado, DenverNot specified NCT05210361
  9. Minor: Ambient AI Scribe (Voa Health) in Outpatient Clinics: Draft Notes, Documentation Burden, and Well-Being Primary and study completion pushed from Oct 28, 2026 to Nov 28, 2026 Pedro Angelo Basei de PaulaNot applicable NCT07302906
  10. Minor: PopSci CHW4CervixHealth Primary and study completion pushed from Oct 1, 2026 to Dec 1, 2026 Thomas Jefferson UniversityNot applicable NCT07336134
  11. Minor: Dysphagia, QoL and Attitudes Towards PEG in ALS Patients Primary and study completion pushed from Sep 30, 2026 to Dec 30, 2026 University Rehabilitation Institute, Republic of SloveniaNot specified NCT05336760
  12. Minor: Moisturization and Skin Hydration Study Primary completion pushed from Dec 2026 to May 2027 University of British ColumbiaNot applicable NCT07270965
  13. Minor: Robot-Aided Off-Axis Neuromuscular Training for Knee OA Primary completion pushed from Jun 1, 2029 to Oct 31, 2029 University of Maryland, BaltimoreNot applicable NCT07014098
  14. Minor: Use of AI Chatbots for Mental Health Primary completion pushed from Oct 2026 to Dec 2026 Medizinische Hochschule Brandenburg Theodor FontaneNot specified NCT07658547
  15. Minor: Extracorporeal Shock Wave Therapy, LASER Therapy and Cryotherapy in Patients Having Sacroiliitis Primary and study completion pushed from Sep 10, 2026 to Dec 10, 2026 Najran UniversityNot applicable NCT06569615
  16. Minor: Brief Mindfulness Training With Vagal Nerve Stimulation on Alcohol Cue Reactivity Among Young Adult Heavy Drinkers Primary and study completion pushed from Aug 2026 to Dec 31, 2026 Cambridge Health AllianceNot applicable NCT07516873
  17. Minor: 5 vs 8 cmH₂O PEEP on Respiratory Mechanics in Prone Lumbar Surgery Primary completion pushed from Sep 2, 2026 to Jan 31, 2027 Harran UniversityNot applicable NCT07545733
  18. Minor: Consciousness Studies and Cardiovascular Health Primary and study completion pushed from Oct 2028 to Dec 2028 University of MiamiNot applicable NCT07620639
  19. Minor: Ultrasound Detection of Body Composition in Critical Care Primary completion pushed from Oct 25, 2026 to Dec 25, 2026 Ain Shams UniversityNot specified NCT06728722
  20. Minor: Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2) Trial sites expanded: 4 → 7 locations GenmabPhase 3 NCT07775287
  21. Minor: EIK1001 in Combination With Pembrolizumab and Chemotherapy · Stage 4 Non-Small Cell Lung Cancer Trial sites expanded: 42 → 52 locations Eikon TherapeuticsPhase 2/3 NCT07365319
  22. Minor: OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events Trial sites expanded: 252 → 261 locations AmgenPhase 3 NCT07136012
  23. Minor: ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL Trial sites expanded: 6 → 9 locations Newave Pharmaceutical IncPhase 3 NCT07342478
  24. Minor: Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) Trial sites expanded: 124 → 129 locations Merck Sharp & Dohme LLCPhase 3 NCT07513376
  25. Minor: Inclisiran to Prevent Cardiovascular (CV) Events · Established Cardiovascular Disease Trial sites expanded: 983 → 989 locations Novartis PharmaceuticalsPhase 3 NCT05030428